Diabetic neuropathy: The painful foot

Foot and Ankle Clinics

Volumn 9, Issue 2, 2004, Pages 221-237

  Hyer, Christopher F ^a   Lee, Thomas H ^a   Philbin, Terrence M ^a   Berlet, Gregory C ^a  

^a Orthopedic Foot and Ankle Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

BLOOD FLOW; CLINICAL FEATURE; DIABETIC FOOT; DISEASE CLASSIFICATION; ELECTRIC ACTIVITY; GLYCATION; HUMAN; INCIDENCE; METABOLIC REGULATION; MORTALITY; NEUROPATHIC PAIN; PATHOGENESIS; REVIEW; RISK FACTOR; SENSITIZATION; SIGNAL TRANSDUCTION;

DIABETIC NEUROPATHIES; FOOT; HUMANS; PAIN; RISK FACTORS;

EID: 2542467723     PISSN: 10837515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fcl.2004.01.002     Document Type: Review

References (87)

1. Soliman E., Gellido C. Diabetic neuropathy. Available at: www.emedicine.com. Accessed March 29, 2002
2. Calcutt N. Future treatments for diabetic neuropathy: clues from experimental neuropathy. Curr Diab Rep. 2:2002;482-488
3. Malik R. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors? Ann Med. 32:2000;1-5
4. Ross M.A. Neuropathies associated with diabetes. Clin Neuro. 77(1):1993;111-124
5. Amos A., McCarty D., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 14(Suppl. 5):1997;S1-S85
6. Adler A. Risk factors for diabetic neuropathy and foot ulceration. Curr Diab Rep. 1:2001;202-207
7. Lipnick J., Lee T. Diabetic neuropathy. Am Fam Physician. 54(8):1996;2478-2484
8. Cameron N., Eaton S., Cotter M., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 44:2001;1973-1988
9. Simmons Z., Feldman E. Update on diabetic neuropathy. Curr Opin Neurol. 15:2002;595-603
10. Prieskorn D. AOFAS Treatment of the foot and ankle. Review Course Manual - 2001. 2001;AOFAS, Seattle (WA)
11. Watkins P.J., Edmonds M.E. Clinical features of diabetic neuropathy. Pickup J.C., Williams G. Textbook of diabetes. vol. 2:1997;1-50 Blackwell Scientific, Boston
12. Lozeron P., Nahum L., Lacroix C., Ropert A., Guglielmi J., Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 249:2002;569-575
13. Perkins A., Morgenlander J. Endocrinologic causes of peripheral neuropathy. Postgrad Med. 102(3):1997;81-106
14. Quattrini C., Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev. 19:2003;S2-S8
15. Sheetz M., King G. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA. 288(20):2002;2579-2588
16. Perkins B., Bril V. Diagnosis and management of diabetic neuropathy. Curr Diab Rep. 2:2002;495-500
17. Ishii D. Implications of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Rev. 20:1995;47-67
18. Ziegler D. Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diab Rep. 1:2001;216-227
19. Younger D., Rosoklija G., Hays A. Diabetic peripheral neuropathy. Semin Neurol. 18(1):1998;95-104
20. Wheeler S., Ahroni J., Boyko E. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 58:2002;131-138
21. Galer B., Dworkin R. A clinical guide to neuropathic pain. 2000;McGraw-Hill, Minneapolis (MN)
22. Veves A., Manes C., Murray H., Young M., Boulton A. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 16(8):1993;1187-1189
23. Spruce M., Potter J., Coppini D. The pathogenesis and management of painful diabetic neuropathy: a review. Diabetic Med. 20:2003;88-98
24. Bennett G. Neuropathic pain, new insights. Hosp Pract. 68:1998;1-18
25. Miki K., Fukuoka T., Tokunaga A., Noguchi K. Calcitonin gene-related peptide increase in the rat spinal horn and dorsal column nucleus following peripheral nerve injury: up-regulation in a subpopulation of primary afferent sensory neurons. Neuroscience. 82:1998;1243-1252
26. Kapur D. Neuropathic pain and diabetes. Diabetes Metab Res Rev. 19:2003;s9-s15
27. Woolf C., Mannion R. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet. 353:1999;1959-1964
28. Marieb E. The peripheral nervous system and reflex activity. Brassert E.C., Earl W., Cameron K., Novak D. Human anatomy and physiology. 4th edition:1998;464-465 Addison-Wesley Longman, New York
29. Benbow S., Cossins L., MacFarlane I. Painful diabetic neuropathy. Diabet Med. 16:1999;632-644
30. Otto M., Bak S., Bach F., Jensen T., Sindrup S. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain. 101:2003;187-192
31. Howe J., Loeser J., Calvin W. Mechanosensitivity of dorsal root ganglia and chronically injured axons: a physiological basis for radicular pain of the nerve root. Pain. 3:1977;25-41
32. Wall P., Gutnick M. Ongoing activity in peripheral nerves; the physiology and pharmacology of impulses originating from neuroma. Exp Neurol. 45:1974;580-593
33. Chan A., MacFarlane I., Bowsher D. Short term fluctuations in blood glucose concentrations do not alter pain perception in diabetic patients with and without painful peripheral neuropathy. Diabetes Res. 14:1990;15-19
34. Cameron N., Eaton S., Cotter M., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 44:2001;1973-1988
35. Tesfaye S., Malik R., Harris N., Jakubowski J., Mody C., Pennie I., et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy or rapid glycaemic control (insulin neuritits). Diabetologia. 39:1996;329-335
36. Boulton A., Ward J. Diabetic neuropathies and pain. Clin Endocrinol Metab. 15:1986;917-931
37. Archer A., Roberts V., Watkins P. Blood flow patterns in painful diabetic neuropathy. Diabetologia. 27:1984;563-567
38. Ellenberg M. Diabetic neuropathic cachexia. Diabetes. 23:1974;418-423
39. Llewelyn J., Thomas P., Fonseca V., King R., Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl). 72:1986;157-163
40. Watkins P. Pain and diabetic neuropathy. BMJ. 288:1984;168-169
41. Asbury A.K. Focal and multifocal neuropathies of diabetes. Dyck P.J., Thomas P.K., Asbury A.K. Focal and multifocal neuropathy. 1987;457-474 WB Saunders, Philadelphia
42. Stevens J., Beard C., O'Fallon W. Conditions associated with carpal tunnel syndrome. Mayo Clin Proc. 67(6):1992;541-548
43. Pirat J. Diabetes mellitus and its degenerative complications: a prospective study of 4, 400 patients observed between 1947 and 1973. Diabetes Cases. 1:1987;252-258
44. Dyck P., Davies J., Wilson D., Service F., Melton L., O'Brien P. Risk factors for severity of diabetic polyneuropathy. Diabetes Care. 22(9):1999;1479-1486
45. Sorensen L., Molyneaux L., Yue D. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract. 57:2002;45-51
46. Singleton J., Smith A., Bromberg M. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 24:2001;1225-1228
47. Oyibo S., Prasad N., Jackson N., Jude E., Boulton A. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 19:2002;870-873
48. Russell J., Feldman E. Impaired glucose tolerance - does it cause neuropathy? Muscle Nerve. 24(9):2001;1109-1112
49. The Diabetes Control and Complications Trial Research Group The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 122:1995;561-568
50. Sugimoto K., Murakawa Y., Sima A. Diabetic neuropathy - a continuing enigma. Diabetes Metab Res Rev. 16:2000;408-433
51. Newrick P., Wilson A., Jakubowski J., Boulton A., Ward J. Sural nerve oxygen tension in diabetes. BMJ. 293:1986;1053-1054
52. Timperley W., Ward J., Preston F., Duckworth T., O'Malley B. Clinical and histological studies in diabetic neuropathy. Diabetologia. 12:1976;237-243
53. Williams E., Timperley W., Ward J., Duckworth T. Electomicroscopical studies of vessels in diabetic neuropathy. J Clin Pathol. 33:1980;462-470
54. Wautier J., Paton R., Wautier M. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med. 305:1981;237-242
55. Ford I., Malik R., Newrick P., Preston F., Ward J., Greaves M. Relationship between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost. 68:1992;628-633
56. Arora S., Pomposelli F., LoGerfo F., Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg. 35:2002;501-505
57. Creager M., Luscher T., Cosentino F., Bechman A. Diabetes and vascular disease: pathophysiology, clinical consequences and medical therapy: part I. Circulation. 108(12):2003;1527-1532
58. Greene D., Lattimer S., Sima A. Sorbitol, phosphoninositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med. 316:1987;599-606
59. Low P. Recent advance in the pathogenesis of diabetic neuropathy. Muscle Nerve. 10:1987;121-128
60. Tuck R., Schmelzer J., Low P. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107:1984;935-950
61. Nathan D. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med. 124(1):1996;86-89
62. Cameron N.E., Cotter M.A. Role of linoleic acid in diabetes polyneuropathy. Dyck P.J., Thomas P.K. Diabetic polyneuropathy. 2nd edition:1999;359-367 WB Saunders, Philadelphia
63. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843
64. Greene D., Arezzo J., Brown M. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology. 53:1999;580-591
65. Obrosova I. How does glucose generate oxidative stress in peripheral nerve? Int Rev Neurobiol. 50:2002;3-35
66. Stitt A., Jenkins A., Cooper M. Advanced glycation end products and diabetic complications. Expert Opin Invest Drugs. 11(9):2002;1205-1223
67. Low P., Nickander K., Trischler H. The role of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 47(9):1997;S38-S43
68. Eaton J., Qian M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem. 234/235:2002;135-142
69. Van Dam P. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev. 18:2002;176-184
70. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids. 44:1987;227-253
71. Nickander K., Schmelzer J., Rohwer D., Low P. Effect of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci. 126:1994;6-14
72. Jack A., Cameron N., Cotter M. Effects of the diacylglycerol complexing agent, cremophor, on nerve conduction velocity and perfusion in diabetic rats. J Diabetes Complications. 13:1999;2-9
73. Cameron N., Cotter M., Dines K., Maxfield E., Carey F., Mirrless D. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin diabetic rats: dose-response considerations and independence from myo-inositol mechanism. Diabetologia. 37:1994;651-663
74. Vinik A., Newlon P., Lauterio T., Liuzzi F., Depto A., et al. Nerve survival and regeneration in diabetes. Diabetes Rev. 3:1995;139-157
75. Srinivasan S., Stevens M., Wiley J. Diabetic peripheral neuropathy. Diabetes. 49(11):2000;1932-1944
76. Low P., Schmeichel A., Schmelzer J., Kishi M. Oxidative stress in the pathogenesis of experimental diabetic neuropathy. J Neurochem. 85(Suppl 2):2003;W4B-W02
77. Low P. Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve. 10:1987;121-128
78. Dyck P., Norell J., Dyck P. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 53(9):1999;2113-2128
79. Glazner G., Lupien S., Miller J., Ishii D. Insulin-like growth factor-II increases the rate of sciatic nerve regeneration in rats. Neuroscience. 54:1993;791-797
80. Kanje M., Skottner A., Sjoberg J., Lundborg G. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res. 486:1989;396-398
81. Near S., Whalen L., Miller J., Ishii D. Insulin-like growth factor-II stimulates motor nerve regeneration. Proc Natl Acad Sci USA. 89:1992;11716-11720
82. Upton A., McComas A. The double crush nerve entrapment syndromes. Lancet. 2:1973;359
83. Zahir K., Zahir F., Thomas J., Dudrick S. The double-crush phenomenon - an unusual presentation and literature review. Conn Med. 63(9):1999;535-538
84. Dellon A., Dellon E., Seiler W. Effect of tarsal tunnel decompression in the streptozotocin-induced diabetic rat. Microsurgery. 15:1994;265-268
85. Dellon A. A cause for optimism in diabetic neuropathy. Ann Plast Surg. 20(2):1988;103-105
86. De Krom M., Kester A., Knipschild P. Risk factors for carpal tunnel syndrome. Am J Epidemiol. 132(6):1990;1102-1110
87. Dyck P.J., Engelstad J.K., Giannini C., Lais A.C., Minnerath S.R., Karnes J.L. Resistance to axonal degeneration after nerve compression in experimental diabetes. Proc Natl Acad Sci USA. 86:1989;2103-2106